EUVIMEDEUVIMED entdecken
Klinische StudieMultizentrische Studie

Early and Midterm Results of a Novel Stented Graft for Patients with Stanford Type A Aortic Dissection

Jue Yang, Jia Hu iD, Yang Yan, Yong Cao, Jinlin Wu iD, Jianfang Luo iD, Tucheng Sun, Changjiang Yu, Xin Li, Yucheng Peng, Yuan Liu, Ruixin Fan

European Journal of Cardio-Thoracic Surgery · 01.12.2025 · 67 (12)

DOI: 10.1093/ejcts/ezaf401 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift European Journal of Cardio-Thoracic Surgery, online erschienen am 13.11.2025. Verfasst von Jue Yang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), So…. Hauptthemen laut MEDLINE: Aortic Aneurysm, Thoracic, Aortic Dissection, Blood Vessel Prosthesis, Blood Vessel Prosthesis Implantation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The objective of this study was to assess the feasibility and effectiveness of the novel stented graft in treating Stanford type A aortic dissection (TAAD).

Methods

This research was a prospective, multicentre, single-arm study that enrolled patients with Stanford TAAD at high risk for open aortic repair. Primary end-points included aorta-related mortality or reintervention at 1 month. Secondary end-points comprised type Ia and III endoleak, major adverse cardiovascular and cerebrovascular events at 1 month, 6 months, and 12 months.

Results

Fifty-three patients were enrolled with a mean age of 63.3 years (range 30-81), of whom 44 (83.0%) were male. Forty-six (86.8%) patients presented with retrograde Stanford TAAD, while the remainder had DeBakey type II aortic dissection. Forty-eight patients (90.6%) were in the acute phase. Carotid-to-subclavian artery bypass was performed in 17(32.1%) patients. The stented graft was successfully delivered via the femoral artery in all cases. Follow-up occurred at 1 month, 6 months, and 12 months. The median follow-up was 6 months (range 1-24). The all-cause mortality was 3.8% (2/53) and the aorta-related mortality was 1.9% (1/53). Six(11.3%) patients required open surgery due to left ventricular rupture (1 patient), retrograde progression of aortic dissection (3 patients), and severe type Ia endoleak (2 patients). Mild type Ia endoleak was observed in 1 patient and 1 patient suffered from cerebral infarction.

Conclusions

The early and midterm results of the first-in-man evaluation of the new stented graft for Stanford TAAD were satisfactory, achieving 100% technical success and 1.9% aorta-related mortality. Clinical Trial Registration Number This clinical trial was registered in the Chinese Clinical Trial Registry under the identifier ChiCTR2200057706 (Chinese Clinical Trial Register (ChiCTR)—The world health organization international clinical trials registered organization registered platform).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic Aneurysm, ThoracicAortic DissectionBlood Vessel ProsthesisBlood Vessel Prosthesis ImplantationStentsAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedEndovascular ProceduresFeasibility StudiesFollow-Up StudiesProspective StudiesTreatment Outcome

Stichwörter der Autor:innen

Stanford type A aortic dissectionTEVARstented graft

Autor:innen und Institutionen

  • Department of Cardiac Surgery, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
  • Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Department of Cardiovascular Surgery, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China.
  • Department of Cardiovascular Surgery, The People's Hospital of Gaozhou, Gaozhou, 525200, China.
  • Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.
  • Shenzhen Chuangxin Medical Technology Co. Ltd, Shenzhen, 518118, China.

ORCID-Profile: Jia Hu, Jinlin Wu, Jianfang Luo

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yang, J., Hu, J., Yan, Y., Cao, Y., Wu, J., Luo, J., Sun, T., Yu, C., Li, X., Peng, Y., Liu, Y., & Fan, R. (2025). Early and Midterm Results of a Novel Stented Graft for Patients with Stanford Type A Aortic Dissection. European Journal of Cardio-Thoracic Surgery, 67(12). https://doi.org/10.1093/ejcts/ezaf401

Vancouver

Yang J, Hu J, Yan Y, Cao Y, Wu J, Luo J, et al. Early and Midterm Results of a Novel Stented Graft for Patients with Stanford Type A Aortic Dissection. European Journal of Cardio-Thoracic Surgery. 2025;67(12). doi:10.1093/ejcts/ezaf401

BibTeX
@article{Yang2025,
  author = {Yang, Jue and Hu, Jia and Yan, Yang and Cao, Yong and Wu, Jinlin and Luo, Jianfang and Sun, Tucheng and Yu, Changjiang and Li, Xin and Peng, Yucheng and Liu, Yuan and Fan, Ruixin},
  title = {Early and Midterm Results of a Novel Stented Graft for Patients with Stanford Type A Aortic Dissection},
  journal = {European Journal of Cardio-Thoracic Surgery},
  year = {2025},
  volume = {67},
  number = {12},
  doi = {10.1093/ejcts/ezaf401}
}
Kostenlos starten →